Resistin, a hormone secreted by adipocytes, is thought to be important in reproduction. Our previous study demonstrated resistin expression in porcine ovarian follicles and its direct effect on steroidogenesis. The aim of the current study was to evaluate the effect of gonadotropins and the local ovarian factors, such as insulin-like growth factor type 1 (IGF1) and steroids (progesterone, testosterone, and 17 beta-estradiol), on the expression and secretion of resistin, as well as its steroidogenic action. Porcine ovarian follicles were exposed to follicle-stimulating hormone (FSH) and luteinizing hormone (LH) at 50-150 ng/ml, IGF1 (10-100 ng/ml), and steroids at 10 À8 to 10 À6 M for 24 h. Then, mRNA, protein expression, and medium concentration of resistin were determined using realtime PCR, Western blot analysis, and ELISA, respectively. In the subsequent experiments, ovarian follicles were exposed to resistin and/or FSH, LH, IGF1, and steroids, and ovarian steroidogenesis was analyzed. Additionally, we examined the direct effect of resistin on the protein expression of receptors for gonadotropins and investigated local factors. The results showed that gonadotropins and steroids have stimulatory effects but that IGF1 has an inhibitory effect on resistin expression and secretion. Resistin decreased gonadotropins and local hormone-induced steroid secretion and inhibited 3beta-hydroxysteroid dehydrogenase, 17beta-hydroxysteroid dehydrogenase, and cytochrome P450 aromatase protein expression. Additionally, we demonstrated that resistin increased the expression of receptors for progesterone and testosterone. These findings all show that the expression and function of resistin are regulated by gonadotropins and local factors produced by ovarian follicles.
INTRODUCTION
Resistin belongs to a multigene family of cysteine-rich Cterminal domain proteins termed ''resistin-like molecules'' (RELMs) or ''found in inflammatory zone'' (FIZZ) proteins [1, 2] . Resistin is produced primarily by adipocytes, although its expression has been detected in the placenta [3] , pancreas [4] , and adrenal gland [5] . In adipose tissue from obese humans, resistin expression is significantly higher than that in normal subjects [6] . Steppan et al. [1] reported that during the differentiation of preadipocytes into adipocytes in 3T3-L1 cells, resistin expression was also increased. Several studies have shown that in adipose cells, resistin expression is regulated by different factors [7] . Negative regulators of resistin expression include insulin [8] , thyroid hormones [9] , insulin-like growth factor type 1 (IGF1) [10] , and peroxisome proliferator-activated receptor c (PPARc) agonists [1, 11] . By contrast, positive regulators of resistin expression include neuropeptide Y [12] and androgens [13] . However, lipopolysaccharides, tumor necrosis factor alpha (TNFa), interleukin 6, endothelin-1, growth hormone, and estrogens have controversial effects on resistin expression [7] . Resistin has been suggested to be the putative hormone linking obesity, type 2 diabetes [1] , and insulin resistance [14] ; however, recent studies have suggested a functional role for resistin in reproduction.
Ovarian resistin expression was found in humans [15, 16] , cows [17] , rats [17, 18] , and pigs [19, 20] . Resistin is also present in the follicular fluid of women [16] and pigs [19, 20] . It is well known that the expression of other adipokines in ovarian cells, such as leptin, adiponectin, and apelin, is modulated by gonadotropins or steroid hormones [21] [22] [23] [24] . Gonadotropins play primary roles in the initiation and maintenance of follicular growth, as well as in the selection of the dominant follicle and its maturation to preovulatory status [25] . The developing responsiveness of follicles to stimulation by gonadotropins may result from changes in the production and alterations in follicular sensitivity to intraovarian paracrine and/or autocrine factors, such as IGF1 and steroid hormones. However, which physiological factors are responsible for the regulation of ovarian resistin expression are still unknown. In our previous study, we demonstrated that rosiglitazone, a synthetic agonist of PPARc, significantly decreased resistin expression in porcine ovarian follicles [26] .
Recent studies indicated that resistin has a direct effect on ovarian follicle function by regulating steroidogenesis and proliferation in different species. In rats, resistin increased progesterone (P4) secretion, with no effects on 17 betaestradiol (E2) secretion, from cultured granulosa cells; by contrast, in cows resistin significantly decreased both P4 and E2 production from granulosa cells [17] . In pigs, resistin stimulated P4, androstenedione (A4), and testosterone (Te) secretion via 3beta-hydroxysteroid dehydrogenase (3bHSD), cytochrome P450 17alpha-hydroxylase (CYP17A1), and 17beta-hydroxysteroid dehydrogenase (17bHSD) expression in ovarian follicles [19, 20] . This finding was similar to that found in human female theca cells, where a stimulatory effect of resistin on androgen production was demonstrated [27] . However, in human granulosa cells, resistin significantly increased steroid hormone secretion in response to IGF1 but not follicle-stimulating hormone (FSH) [16] .
Based on these observations, we hypothesized that resistin expression and steroidogenic action in ovarian follicles are regulated by gonadotropins and local factors produced by ovarian cells, such as IGF1 and steroids (P4, Te, and E2). Therefore, in the present study we investigated 1) the effect of gonadotropins and local factors on resistin expression and concentration in ovarian follicles; 2) resistin action on gonadotropins and local factors in the induction of steroid secretion and the protein expression of 3bHSD, 17bHSD, and cytochrome P450 aromatase (CYP19A1); and 3) the direct effects of resistin on the protein expression of receptors for gonadotropin (FSH receptor [FSHR] and luteinizing hormone receptor [LHCGR]), the a and b subunits of IGF1 (IGF1Ra/b), progesterone receptor (PR), androgens (AR), and estrogen receptor beta (ERb).
MATERIALS AND METHODS

Reagents
M199 medium, fetal bovine serum (heat inactivated), and PBS were purchased from GmbH. Antibiotic-antimycotic solution (1003), Tris, Nadeoxycholate, Nonidet NP-40, SDS, protease inhibitors (ethylene diamine tetraacetic acid-free), dithiothreitol, Tween 20, bromophenol blue, 1 bromo-3-chloro-propane, FSH from porcine pituitary (catalogue no. F2293), luteinizing hormone (LH) from sheep pituitary (catalogue no. L5269), human recombinant IGF1 (catalogue no. I3769), synthetic steroids P4, Te, and E2 (catalogue nos. P0130, 86500, and E2257, respectively), rat resistin (catalogue no. SRP4561), and Western blotting luminol reagent (catalogue no. sc-2048) were obtained from Sigma-Aldrich. Rat recombinant resistin was used in this experiment because porcine resistin was not readily available at the onset of the experiment. Rat resistin differs from porcine resistin by five amino acids [7] . A Bradford protein assay kit was obtained from Bio-Rad Laboratories. Polyvinylidene difluoride membrane was purchased from Merck Millipore.
Antibodies
Antibodies against resistin (catalogue no. sc-17575), FSHR (catalogue no. sc-7798), LHCGR (catalogue no. sc-26341), IGF1Ra/b (catalogue no. sc-9038), AR (catalogue no. sc-816), ERb (catalogue no. sc-8974), 3bHSD (catalogue no. sc-30820), 17bHSD (catalogue no. sc-66415), and CYP19A1 (catalogue no. sc-14244), as well as horseradish peroxidase-conjugated antibody (catalogue no. sc-2020), were obtained from Santa Cruz Biotechnology. As a positive control for resistin antibody we used protein extracted from porcine adipose tissue [19] . The antibody against PR (catalogue no. 3176) was obtained from Cell Signaling Technology (Cell Signaling Technology Inc.). Anti-b-actin antibody (catalogue no. A5316) was obtained from SigmaAldrich. Antibodies for Western blot analysis were recommended for porcine tissues and were used in our previous studies [19, 20] .
Sample Collection and Ovarian Follicle Incubation
Porcine ovaries were collected from mature (ages 7-8 mo) crossbred gilts (Large White and Polish Landrace) at a local abattoir. Ovaries were collected in a bottle filled with sterilized ice-cold saline containing antibiotic-antimycotic solution and were transported to the laboratory. Approximately 1 h elapsed from slaughter to collection in the laboratory. Medium-size follicles (4-5 mm) were obtained from the ovaries of pigs on Days 10-12 of the estrous cycle as described previously [28] . Estrus was designated as Day 0. After isolation, ovarian follicles were cut using small scissors to facilitate the penetration of the compounds into the tissue. Follicular walls, including theca and granulosa cells and excluding oocytes and follicular fluids, were individually placed in 24-well plates in M199 medium without phenol red that was supplemented with antibiotic-antimycotic solution and reagents. The follicles were maintained at 378C in a humidified atmosphere containing 5% CO 2 for 24 h.
Experimental Procedure Experiment 1. Effect of gonadotropins and local ovarian hormones on resistin expression and concentration. Ovarian follicles were exposed to FSH and LH at 50, 100, and 150 ng/ml; IGF1 at doses of 10, 30, 50, and 100 ng/ml; and the steroids P4, Te, and E2 at 10 À8 , 10
À7
, and 10 À6 M, respectively, for 24 h. The doses of hormones were chosen based on previous observations [29] . After incubation, 250 ll of medium was separated from the follicles and stored at À208C for resistin concentration analysis. Part of the cultured follicles were homogenized twice in ice-cold lysis buffer (50 mM Tris-HCl [pH 7.5] containing 100 mM NaCl, 0.5% sodium deoxycholate, 0.5% NP-40, 0.5% SDS, and protease inhibitors), and lysates were cleared by centrifugation at 15 000 3 g at 48C for 30 min. Protein content was determined by a protein assay using bovine serum albumin as a standard. All samples were stored at À208C for resistin protein expression analysis. To analyze resistin mRNA expression, some ovarian follicles were immediately frozen in liquid nitrogen and then stored at À708C. The total number of ovarian follicles in this experiment was 88. Each treatment was conducted in four wells, and each experiment was repeated three times (n ¼ 3).
Experiment 2. Effect of resistin on gonadotropins and local ovarian hormone-induced steroidogenesis. Ovarian follicles were exposed to FSH or LH at 100 ng/ml, or IGF1 (30 ng/ml) or P4 or Te at a dose of 10 7 M alone or with combination with resistin (0.1, 1, and 10 ng/ml) for 24 h. The doses of resistin were chosen based on previous observations [20, 21] . After incubation, 250 ll of medium was separated from the follicles and stored at À208C for steroid hormone secretion analysis. Ovarian follicles were homogenized twice in ice-cold lysis buffer, lysates were cleared by centrifugation at 15 000 3 g at 48C for 30 min, and protein content was determined as described in experiment 1. All samples were stored at À208C for 3bHSD, 17bHSD, and CYP19A1 protein expression analysis. The total number of ovarian follicles in this experiment was 112. Each treatment was conducted in four wells, and each experiment was repeated three times (n ¼ 3).
Experiment 3. Effect of resistin on protein expression of receptors: FSHR, LHCGR, IGF1Ra/b, PR, AR, and ERb. Ovarian follicles were exposed to resistin at 0.1, 1, and 10 ng/ml doses for 24 h. After incubation, medium was removed and cultured follicles were homogenized twice in ice-cold lysis buffer, lysates were cleared by centrifugation at 15 000 3 g at 48C for 30 min, and protein content was determined as in the previous experiment. All samples were stored at À208C for FSHR, LHCGR, IGF1Ra/b, PR, AR, and ERb protein expression analysis. The total number of ovarian follicles in this experiment was 16. Each treatment was conducted in four wells, and each experiment was repeated three times (n ¼ 3).
Total RNA Isolation
Total RNA from ovarian follicles was extracted with Tri Reagent solution reagent according to the manufacturer's protocol (Applied Biosystems). RNA concentrations were determined by spectrophotometry at 260 and 280 nm using a DS-11 Spectrophotometer (DeNovix), and 1 lg of RNA was used for reverse transcription.
RT and Real-Time PCR
Reverse transcription was performed using the Transcriptor First Strand cDNA Synthesis kit (Roche Applied Science) in combination with 50 pmol/ll anchored-oligo (dT)18 primer and 600 pmol/ll random hexamer primers according to the manufacturer's protocol.
Real-time PCR was performed as previously described [20] using TaqMan Gene Expression assays (Applied Biosystems) with specific probes for resistin (RETN; Ss03381389_u1; NM_213783.1) and GAPDH (Ss03375629_u1; NM_001206359.1). Relative quantification (RQ) was obtained using the 2 ÀDDCt method, adjusting the target gene to GAPDH and measuring the adjusted expression in the control group (RQ ¼ 1).
Western Blotting
Tissue preparation, lysis, Western blotting, and quantification were performed as previously described [19] . In brief, the samples were separated by 12% SDS-PAGE (BioRad Mini-Protean II Electrophoresis Cell) for resistin, steroidogenic enzymes, and ERb; 8% SDS-PAGE for AR, PR, FSHR, and LHCGR; and 6% SDS-PAGE for IGF1Ra/b. Proteins were transferred to polyvinylidene difluoride membranes and incubated with antibodies diluted to 1:200 at 48C overnight. Then, the membranes were incubated with a horseradish peroxidase-conjugated antibody diluted to 1:500. Signals were detected by chemiluminescence using the Western blotting Luminol Reagent and visualized using a ChemiDoc-It Imaging System (UVP LLC). All bands visualized by chemiluminescence were quantified using the ImageJ analysis software (National Institutes of Health). The blots were stripped and probed for anti-b-actin.
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ELISA Methods
Steroid hormone (i.e., P4, Te, and E2) levels were determined in conditioned culture media using commercially available ELISA kits (catalogue nos. EIA-1561, EIA-1559, and EIA-2693; DRG MedTek Sp. z o.o). The sensitivity of each assay was 0.045 ng/ml for P4, 0.083 ng/ml for Te, and 9.714 pg/ml for E2, with ranges of 0-40 ng/ml, 0-16 ng/ml, and 0-2000 pg/ml, respectively. The interexperimental and intraexperimental coefficients of variation were 4.34% and 6.99%, respectively, for P4; 6.71% and 3.28%, respectively, for Te; and 6.72% and 2.71%, respectively, for E2. All samples were assayed in duplicate in the same assay.
A commercially available human resistin ELISA (catalogue no. EK-028-36; Phoenix Pharmaceuticals Inc.) was used to quantify resistin concentrations in culture medium. The sensitivity of the resistin assay was 0.016-1 ng/ml, and the interexperimental and intraexperimental coefficients of variation were 15% and 10%, respectively. Samples were run in triplicate within the same assay.
Statistical Analysis
All of the experiments were performed independently three times. A oneway ANOVA was used for multiple comparisons involving more than two treatment groups. The Tukey honest significant difference multiple-range test was performed post hoc (GraphPad PRISM v. 4.0; GraphPad Software Inc.). All data are expressed as mean 6 SEM. Statistical significance is indicated by different letters (P , 0.05) or by *P , 0.05, **P , 0.01, and ***P , 0.001.
RESULTS
Effect of Gonadotropins on Resistin Expression and Concentration
Statistically significant increases in resistin mRNA expression of 2.6-, 2.7-, and 2.6-fold compared with control values were observed with FSH treatments of 50, 100, and 150 ng/ml, respectively, and 1.9-, 2-, and 1.8-fold compared with control values with LH at doses of 50, 100, and 150 ng/ml, respectively (P , 0.01, P , 0.001; Fig. 1A ). In parallel, Figure 1B shows that both FSH and LH significantly increased resistin protein expression by Western blot analysis (P , 0.001). The concentration of resistin in culture medium showed a significant increase after FSH (0.871, 0.838, and 0.966 ng/ml at 50, 100, and 150 ng/ml, respectively) and LH (0.92, 0.881, and 0.878 ng/ml at 50, 100, and 150 ng/ml, respectively) treatment compared with the controls (0.585 ng/ml; P , 0.001; Fig. 1C ).
Effect of Resistin on Gonadotropin-Induced Steroid Secretion and Protein Expression of 3bHSD, 17bHSD, and CYP19A1
We next investigated whether the supplementation of FSH and LH at a 100 ng/ml dose changed resistin action on ovarian steroidogenesis. After 24 h of treatment, steroid hormone secretion was measured by ELISA of the culture medium, and 3bHSD, 17bHSD, and CYP19A1 protein expression was assessed in ovarian follicles. Secretion of P4 was significantly increased to 39.567 ng/ml after FSH treatment and 39.223 ng/ ml after LH treatment compared with the 16.559 ng/ml value obtained from controls (P , 0.05; Fig. 2A ). Resistin at 0.1, 1, and 10 ng/ml doses statistically significantly decreased FSHinduced (19.7, 18.8, and 22.7 ng/ml, respectively, vs. 39.567 ng/ml for FSH treatment) and LH-induced (17.8, 18.8, and 20.8 ng/ml, respectively, vs. 39.223 ng/ml for LH treatment) P4 secretion. In parallel, although 3bHSD protein expression was significantly higher in FSH-and LH-treated follicles, it returned to the control levels in combination with resistin (P , 0.05; Fig. 2A) . Figure 2B showed that Te secretion was increased after FSH and LH treatment to 14.989 and 19.911 ng/ml, respectively, versus 8.472 ng/ml in controls (P , 0.05). We observed that resistin and gonadotropins induced decreased Te secretion: 10.1, 11.1, and 7.21 ng/ml, respectively, versus 14.989 ng/ml for FSH treatment, and 2.1, 3.2, and 1.2 ng/ml, respectively, versus 14.911 ng/ml for LH treatment (P , 0.05; Fig. 2B ). Western blot analysis showed that protein expression of 17bHSD was significantly increased in gonadotropin-treated follicles; however, in combination with resistin this expression returned to control levels (P , 0.05; Fig. 2B ).
We observed that FSH and LH significantly increased E2 secretion: 1072.197 and 1097.371 pg/ml, respectively, versus 560.208 pg/ml in the control (P , 0.05; Fig. 2C ). Resistin at all doses in combination with gonadotropin significantly decreased E2 secretion: 624.727, 718.445, and 720.246 pg/ml, respectively, versus 1072.197 pg/ml for FSH treatment; and 690.419, 677.463, and 689.908 pg/ml, respectively, versus 1097.371 pg/ml for LH treatment (P , 0.05; Fig. 2C) . Similarly, analysis of CYP19A1 protein expression demonstrated that both gonadotropins significantly increased CY-P19A1 expression, but in combination with resistin this expression returned to control levels (P , 0.05; Fig. 2C ).
Effect of IGF1 on Resistin Expression and Concentration
We observed that IGF1 at 50 and 100 ng/ml doses significantly decreased resistin mRNA expression by 0.734-and 0.661-fold versus controls, respectively (P , 0.05; Fig.  3A ). Western blot analysis showed that resistin protein expression was significantly decreased at 30, 50, and 100 ng/ ml IGF1 treatment (P , 0.01; P , 0.001; Fig. 3B ). Additionally, the inhibitory effect of IGF1 at 30, 50, and 100 ng/ml (0.375, 0.205, and 0.245 ng/ml, respectively, versus 0.561 ng/ml for controls) on resistin concentration in culture medium is shown in Figure 3C (P , 0.05; P , 0.001).
Effect of Resistin on IGF1-Induced Steroid Secretion and Protein Expression of 3bHSD, 17bHSD, and CYP19A1 IGF1 at 30 ng/ml significantly increased the secretion of all investigated steroids: P4 secretion was 25.043 ng/ml versus 18.072 ng/ml in controls; Te secretion was 13.584 ng/ml versus 9.740 ng/ml in controls; and E2 secretion was 1111.379 pg/ml versus 872.652 pg/ml in controls (P , 0.05; Fig. 4 ). Resistin at 0.1, 1, and 10 ng/ml cultured with IGF1 significantly decreased P4 secretion to 20.349, 19.05, and 17.028 ng/ml, respectively, versus 25.043 ng/ml for IGF1 treatment; Te secretion to 8.344, 9.319, and 10.233 ng/ml, respectively, versus 13.584 ng/ml for IGF1 treatment; and E2 secretion to 858.561, 844.804, and 895.008 pg/ml, respectively, versus 1111.379 for IGF1 treatment (P , 0.05; Fig. 4 ). We observed that IGF1 had a stimulatory effect on 3bHSD, 17bHSD, and CYP19A1 protein expression; however, resistin at all investigated doses in combination with IGF1 significantly decreased the protein expression levels of all investigated steroid enzymes to the control levels (P , 0.05; Fig. 4) .
Effect of Steroid Hormones on Resistin Expression and Concentration
The effect of steroid hormones on resistin mRNA, protein expression, and concentration in culture medium is shown in Figure 5 . Administration of Te and E2 at doses from 10 À8 to 10 À6 M significantly increased resistin mRNA expression by 1.4-, 1.3-and 1.5-fold versus the control and 1.3-, 1.4-, and 1.4-fold versus the control, respectively (P , 0.05; P , 0.01; Fig. 5A ). However, no effect of P4 on resistin mRNA expression was observed. We observed that resistin protein REGULATION Fig. 5B) . Thereafter, the concentration of resistin in culture medium was significantly increased after P4 (0.852 and 0.941 ng/ml at 10 À8 and 10 À7 M, respectively), Te (0.704 and 0.956 ng/ml at 10 À7 and 10 À6 M, respectively), and E2 (0.663, 0.692, and 0.811 ng/ml at 10 À8 , 10 À7 , and 10 À6 M, respectively) treatments compared with 0.516 ng/ml for the control (P , 0.05, P , 0.01, P , 0.001; Fig. 5C ).
Effect of Resistin on P4-and Te-Induced Steroid Secretion and Protein Expression of 17bHSD and CYP19A1
In ovarian follicles, treatment with P4 at 10 À7 M led to significantly higher Te (15.442 vs. 10.662 ng/ml for control) and E2 (1074.333 vs. 680.188 pg/ml for control) secretion compared with control follicles (P , 0.05; Fig. 6A ). Additionally, protein expression of 17bHSD and CYP19A1 was increased significantly after P4 administration. We found that resistin at 1 and 10 ng/ml cultured with P4 significantly decreased Te secretion: 11.476 and 12.472 ng/ml, respectively, versus 15.442 ng/ml for P4 treatment, and only at the 10 ng/ml dose was 17bHSD protein expression decreased (P , 0.05; Fig. 6A ). However, resistin at all doses used in combination with P4 had no effect on either E2 secretion or CYP19A1 protein expression.
Additionally, Te at a 10 À7 M dose significantly increased E2 secretion (1178.611 vs. 680.188 pg/ml for control) and CYP19A1 protein expression (P , 0.05; Fig. 6B ). Resistin at 0.1, 1, and 10 ng/ml cultured with Te significantly decreased E2 secretion-883.731, 892.759, and 752.259 pg/ml, respectively, versus 1178.611 pg/ml for Te-treated follicles-and CYP19A1 protein expression (P , 0.05; Fig. 6B ).
Effect of Resistin on Protein Expression of Receptors: FSHR, LHCGR, IGF1Ra/b, PR, AR, and ERb
We also determined whether resistin can have an effect on the protein expression of receptors for gonadotropins, IGF1, and steroid hormones. As shown in Figure 7 , A and B, resistin at all doses did not have an effect on FSHR, LHCGR, or IGF1Ra/b protein expression. Interestingly, resistin significantly increased the protein expression of PR and AR, without an effect on ERb (P , 0.05; Fig. 7C ).
DISCUSSION
In the present study, we reported that several factors are involved in resistin expression and steroidogenic function in ovarian follicles. For the first time, we demonstrated that gonadotropins and steroid hormones increased resistin expression in ovarian follicles. By contrast, IGF1 significantly decreased resistin expression. However, in ovarian follicles
Effect of FSH and LH (50, 100, and 150 ng/ml) on resistin expression and concentration in ovarian follicles. A) The mRNA expression level of resistin was determined by real-time PCR and normalized to the expression of GAPDH. B) The amount of protein (50 lg) in each sample was confirmed by immunoblotting using an anti-bactin antibody; the protein levels of resistin (12 kDa) were densitometrically scanned and normalized against the b-actin (42 kDa) signal. C) Levels of resistin concentration in the culture medium were measured by ELISA. Real-time PCR, Western blotting, and ELISA experiments were independently performed and repeated three times (n ¼ 3). The data are plotted as the mean 6 SEM. Significance between control and gonadotropin treatments is indicated by **P , 0.01 and ***P , 0.001. C, control.
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FIG. 2. Effect of resistin (0.1, 1, and 10 ng/ml) on FSH-induced (100 ng/ml) and LH-induced (100 ng/ml) steroidogenesis in ovarian follicles. A) Progesterone secretion and 3bHSD protein expression. B) Testosterone secretion and 17bHSD protein expression. C) Estradiol secretion and CYP19A1 protein expression. Steroid hormone secretion was measured by ELISA. The amount of protein (30 lg) in each sample was confirmed by immunoblotting using an anti-b-actin antibody; the protein levels of 3bHSD (42 kDa), 17bHSD (35 kDa), and CYP19A1 (50 kDa) were densitometrically scanned and normalized against b-actin (42 kDa) signal. The ELISA and Western blotting experiments were independently performed and repeated three times (n ¼ 3). The data are plotted as the mean 6 SEM. Different letters indicate significant differences among the groups (P , 0.05). C, control.
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cultured with resistin and all investigated factors, except E2, we observed that the steroid secretion and protein expression of steroidogenic enzymes decreased to control levels. In additional experiments, we observed that resistin significantly increased the protein expression of receptors for P4 and Te, without an effect on ERb, FSHR, LHCGR, and IGF1Ra/b expression (Fig. 8) .
Regulatory Effect of Gonadotropins on Resistin Expression and Steroidogenic Action on Ovarian Follicles
We have demonstrated that both FSH and LH increased mRNA and protein expression as well as resistin secretion in the culture medium during a 24-h ovarian follicle culture. In rat testis, Nogueiras et al. [30] used a gonadotropin-deficient background (i.e., the HPX model) and a normal gonadotropin background model to demonstrate the stimulatory effects of pituitary gonadotropins on resistin mRNA expression. Additionally, our results are in agreement with previous studies that reported that gonadotropins are involved in the regulation of expression of other adipokines in ovarian cells. Studies by Siawrys and Smolinska [21] demonstrated that LH is involved in the control of leptin gene expression in porcine luteal cells and stimulates the level of leptin mRNA in those cells. The results obtained by Chabrolle et al. [23] demonstrated that adiponectin and AdipoR1 expression in immature rat ovaries increased significantly in response to human chorionic gonadotropin (LH-like hormone) treatment. The adiponectin concentration in follicular fluid from human ovaries was higher after recombinant LH treatment [31] . The most recent study by Wickham et al. [32] showed that both FSH and human chorionic gonadotropin increased the mRNA expression of AdipoR2 in cultured human granulosa cells. The expression of apelin and its receptor (APJ) was increased by LH treatment in cultured theca cells; by contrast, expression was decreased by FSH treatment in cultured granulosa cells from cow ovaries [24] . Several studies showed that the hormonal interactions of the hypothalamic-pituitary-ovarian axis are accountable for normal ovarian activity. Follicle-stimulating hormone plays a role in weaning in regulating the number of ovarian follicles that mature, and in granulosa cell proliferation and apoptosis [33] , whereas LH is the principal luteotrophic signal in pigs, cows, and sheep, and is necessary for normal development of the corpus luteum and maintenance of its function [34, 35] . For the first time, these observations suggest that gonadotropins are also involved in the regulation of resistin expression in ovarian follicles.
In the next experiments, we analyzed the participation of gonadotropins in resistin steroidogenic action in ovarian follicles. Previous observations showed that resistin significantly increased P4 and A4 secretion by activation of 3bHSD and 17bHSD protein expression, without affecting E2 secretion and CYP19A1 protein expression in porcine ovarian follicles (10, 30, 50 , and 100 ng/ml) on resistin expression and concentration in ovarian follicles. A) The mRNA expression level of resistin was determined by real-time PCR and normalized to the expression of GAPDH. B) The amount of protein (50 lg) in each sample was confirmed by immunoblotting using an anti-b-actin antibody; the protein levels of resistin (12 kDa) were densitometrically scanned and normalized against b-actin (42 kDa) signal. C) The resistin concentration in the culture medium was measured by ELISA. Real-time PCR, Western blotting, and ELISA experiments were independently performed and repeated three times (n ¼ 3). The data are plotted as the mean 6 SEM. Significance between control and IGF1 treatments is indicated by *P , 0.05, **P , 0.01 and ***P , 0.001. C, control.
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FIG. 4. Effect of resistin (0.1, 1, and 10 ng/ml) on IGF1-induced (30 ng/ml) steroidogenesis in ovarian follicles. A) Progesterone secretion and 3bHSD protein expression. B) Testosterone secretion and 17bHSD protein expression. C) Estradiol secretion and CYP19A1 protein expression. Steroid hormone secretion was measured by ELISA. The amount of protein (30 lg) in each sample was confirmed by immunoblotting using an anti-b-actin antibody; the protein levels of 3bHSD (42 kDa), 17bHSD (35 kDa), and CYP19A1 (50 kDa) were densitometrically scanned and normalized against b-actin (42 kDa) signal. The ELISA and Western blotting experiments were independently performed and repeated three times (n ¼ 3). The data are plotted as the mean 6 SEM. Different letters indicate significant differences among the groups (P , 0.05). C, control.
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FIG. 5. Effect of steroid hormones (10
À8
, 10
À7
, and 10 À6 M) on resistin expression and concentration in ovarian follicles. A) The mRNA expression of resistin was determined by real-time PCR and normalized to the expression of GAPDH. B) The amount of protein (50 lg) in each sample was confirmed by immunoblotting using an anti-b-actin antibody; the protein levels of resistin (12 kDa) were densitometrically scanned and normalized against b-actin (42 kDa) signal. C) Levels of resistin in the culture medium were measured by ELISA. Real-time PCR, Western blotting, and ELISA experiments were independently performed and repeated three times (n ¼ 3). The data are plotted as the mean 6 SEM. Significance between control and steroid hormone treatments is indicated by *P , 0.05, **P , 0.01, and ***P , 0.001. C, control.
RAK ET AL. RAK ET AL. [19, 20] . Moreover, resistin increased androgen production by human cultured theca cells [27] . Similar data showed the same phenomenon in bat (Scotophilus heathi) ovaries [36] . Collectively, these results are suggestive of a role for resistin in polycystic ovary syndrome. The present results demonstrated that resistin decreased gonadotropin-induced steroid secretion by inhibition of 3bHSD, 17bHSD, and CYP19A1 protein expression, suggesting that gonadotropins can protect against excessive secretion of steroids by ovarian follicles exposed to resistin. However, a previous study showed that resistin had no effect on P4 and E2 secretion in response to FSH in human granulosa cells collected from preovulatory follicles from women undergoing in vitro fertilization procedures [16] . This difference is probably due to the culture model used. The participation of gonadotropins on the action of other adipokines on ovarian steroidogenesis has been previously described in pigs, cows, and rats. Our previous study showed that in cultured porcine ovarian follicles, leptin inhibits FSH-induced Te secretion [29] . In cow granulosa cells, leptin decreased gonadotropin-induced steroidogenesis [37] . Furthermore, Wang et al. [38] showed that in rat ovarian cells, chemerin decreased FSH-induced E2 secretion by inhibition of CY-P19A1 expression. Our results demonstrated that resistin had no effect on FSHR and LHCGR protein expression in ovarian follicles. Thus, the molecular mechanism of resistin and gonadotropin action is still unknown. Moreover, the resistin receptor has not yet been identified, and the molecular mechanism of resistin action remains unclear. However, our previous study demonstrated that PPARc is a new key regulator of resistin expression and steroidogenic function [26] .
FIG. 8. Schematic diagram illustrating a possible role by which resistin affects porcine ovarian follicles function based on the current study and previously published data [20] . (1) Regulation of resistin ovarian expression; (2) effect of resistin on basal [20] and FSH-, LH-, and IGF1-induced steroidogenesis; and (3) effect of resistin on expression of receptors: FSHR, LHCGR, IGF1R, PR, AR, and ERb. " indicates stimulatory effect; #, inhibitory effect; and (-), no effect.
REGULATION OF RESISTIN EXPRESSION AND STEROIDOGENESIS
Regulatory Effect of IGF1 on Resistin Expression and Steroidogenic Action on Ovarian Follicles
We also found that resistin expression and secretion may be dependent on the concentration of factors produced locally in the ovarian follicles. Locally produced factors play an important role in follicle growth and differentiation during the early and later stages of development. IGF1 is one of several growth factors that play important roles in the regulation of follicular cell steroidogenesis and proliferation [39, 40] . IGF1 affected the FSH-induced enhancement of P4, estrogen, and cAMP production, as well as LH receptor induction [41] . The hormone-induced secretion of IGF1 appears to serve as an important autocrine mechanism that regulates follicle growth and differentiation. Our study demonstrated that IGF1 dose-dependently significantly decreased both resistin expression and secretion in cultured ovarian follicles. This finding is in agreement with an observation by Chen et al. [10] , who demonstrated that IGF1 suppressed resistin mRNA expression and protein secretion in a 3T3-L1 adipose cell line. Additionally, a study by Chiba et al. [42] showed that suppression of the GH/IGF1 axis markedly downregulated resistin mRNA expression by rat white adipose tissue. Insulin also decreased resistin mRNA expression [43, 44] . Moreover, resistin could interfere with some components of IGF1 receptor signaling, such as insulin receptor substrate 1 (IRS1) [45] .
Our present data showed that resistin at all doses decreased IGF1-induced steroidogenesis. This effect is in agreement with the literature. Resistin significantly reduced P4 and E2 secretion in response to IGF1 in human granulosa cells [16] . The authors of this paper also demonstrated that resistin decreased the IGF1-induced tyrosine phosphorylation of the IGF1Rb subunit and phosphorylation of MAPK ERK1/2, and suggested that the MAPK ERK1/2 signaling pathway regulated in vitro steroidogenesis in humans and rats [16] . In this study, no effect of resistin on IGF1Ra/b protein expression was observed; however, our unpublished study showed that resistin activated the phosphorylation of the ERK1/2 pathway in cultured porcine ovarian cells. Similar results were found for other adipokines, such as leptin or chemerin, which decreased IGF1-induced steroid secretion by granulosa cells [46, 47] .
Interestingly, the present results showed similar effects for resistin action on gonadotropin and IGF1-induced steroidogenesis. It is well documented that gonadotropin and IGF1 synergize on several aspects of ovarian function, such as steroid synthesis, cell proliferation, and apoptosis. However, we observed a difference in the regulation of resistin expression; gonadotropins increased resistin expression, whereas IGF1 decreased resistin expression. This differing effect may result from the fact that IGF1 is correlated with insulin resistance and diabetes [48] , as is resistin. Also, the structure of IGF1 is similar to that of proinsulin, and the effect of IGF1 on resistin expression is similar to that of insulin [48] . Insulin appears to suppress resistin mRNA expression in 3T3-L1 adipocytes [49] . Consistent with the role of insulin sensitization, thiazolidinediones also decrease resistin expression in vitro [26, 50] . Moreover, IGF1 and gonadotropins may use different kinases/signaling pathways to affect resistin expression.
Regulatory Effect of Steroids on Resistin Expression and Steroidogenic Action on Ovarian Follicles
To our knowledge, this is the first study to evaluate the expression and secretion of resistin in response to steroid hormone treatment in ovarian follicles. The results showed that P4 at doses of 10 À8 and 10 À7 M stimulated resistin protein expression and secretion without affecting resistin mRNA, thus suggesting differences in posttranscriptional regulation or protein stability. Moreover, high protein expression may suppress mRNA expression, and high gene expression may diminish posttranscriptional processes [51] . A study by Caja and Puerta [52] showed that P4 increased resistin expression in white adipose tissue. Moreover, we observed that P4 at a higher dose (10 À6 ) had no effect on resistin expression, suggesting that the effects of P4 vary depending on the dose. We demonstrated that both Te and E2 significantly increased mRNA and protein levels of resistin as well as its secretion into the culture medium. Resistin expression in male tissues is higher than that in females, and Te increases adipose tissue resistin mRNA expression in male rats [5, 9] . Furthermore, Ling et al. [53] showed that elevated androgen levels are closely correlated with increased resistin secretion in mice. Additionally, dehydroepiandrosterone induced resistin mRNA expression in the white adipose tissue of male rats [54] . The results concerning the regulation of resistin expression by estrogens are controversial. Although Huang et al. [55] published results confirming the inhibitory effect of estrogens on resistin expression in adipocytes in vivo and in vitro, a year later Chen et al. [56] demonstrated that E2 stimulates resistin mRNA expression in 3T3-L1 adipocyte cells by 100%-250%. Resistin secretion from adipose tissue may be controlled by octylphenol environmental estrogen, because a study by Lee et al. [57] showed a 50% increase in resistin mRNA and protein expression in a 3T3-L1 cell line exposed to this compound. Similar to our results, Siawrys and Smolinska [21] demonstrated a stimulatory effect of P4 and E2 on leptin mRNA expression and secretion by porcine luteal cells in vitro.
Steroids, as local regulators of ovarian activity, are now documented as regulators of resistin action in porcine ovaries. In our in vitro experiments, we demonstrated that resistin significantly decreased P4-induced Te secretion and Teinduced estradiol secretion through the inhibition of 17bHSD and CYP19A1 protein expression. Estradiol regulated the production of androgens and P4 within bovine and porcine ovaries. It is a well-known fact that a local feedback loop exists in ovarian follicles, where androgens produced by theca cells are used as a substrate for granulosa cell aromatization into estrogens, which in turn may feedback to stimulate theca cell production of androgens [58] . The expression of steroid hormone receptors was detected in ovarian follicle cells. For example, PR was found in both the granulosa and theca cells of large porcine follicles, and its expression is positively regulated by both LH and FSH [59] . Intense AR immunostaining was present in the nuclei of porcine granulosa cells of preantral and antral follicles [60] . In the present results, we showed that resistin increased the protein expression of PR and AR, without any effect on ERb. The results of these studies are probably associated with previous observations that resistin has a stimulatory effect on P4, A4, and Te secretion by ovarian follicles, without effects on E2 secretion and CYP19A1 expression [19] .
In summary, the results of the present study provide novel insights into the regulation of resistin expression and steroidogenic function in ovarian follicles (Fig. 8) . We demonstrated that both gonadotropins and steroids increased, but IGF1 decreased, resistin expression and secretion by cultured ovarian follicles. Independent of the regulation of resistin expression, we observed that resistin significantly decreased induction of steroid secretion by gonadotropins and local factors, and inhibited 3bHSD, 17bHSD, and CYP19A1 RAK ET AL.
protein expression. Additionally, we showed that resistin had a stimulatory effect on PR and AR expression but had no effect on FSHR, LHCGR, and IGF1Ra/b. Collectively, these findings show that the expression and function of resistin are regulated by many important factors in ovarian follicles.
